← Back to Clinical Trials
Recruiting NCT05651945

NCT05651945 Cardiac Rehabilitation of Stroke Survivors (SRP-CROSS)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05651945
Status Recruiting
Phase
Sponsor Hackensack Meridian Health
Condition Stroke
Study Type INTERVENTIONAL
Enrollment 150 participants
Start Date 2023-01-20
Primary Completion 2027-01-20

Trial Parameters

Condition Stroke
Sponsor Hackensack Meridian Health
Study Type INTERVENTIONAL
Phase N/A
Enrollment 150
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2023-01-20
Completion 2027-01-20
Interventions
Cardiac rehabilitation program

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This study examines the effectiveness of the cardiac rehabilitation program for stroke patients. The study will examine if patients with stroke, who receive cardiac rehabilitation in addition to their standard of care treatments, demonstrate improved recovery of function. It will also examine if these patients have reduced hospital readmission, reduced rate of recurrent stroke, and mortality.

Eligibility Criteria

Inclusion Criteria: * 18 years or older * Stroke diagnosis (ischemic or hemorrhagic) / radiologic evidence of acute stroke * Medically cleared by a cardiologist for participation in the cardiac rehabilitation program with no contraindications to cardiac rehabilitation per American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR) guidelines * Ability to transfer on/off the recumbent bike with or without an assistive device safely, with or without assistance from another person * Ability to follow simple commands and communicate pain or distress * Admission to an Inpatient Rehabilitation Facility post-stroke * Signed informed consent form Exclusion Criteria: * Presence of subarachnoid hemorrhage, intracranial aneurysm, intracranial hemangioma, or arteriovenous malformation * Medical disorders that preclude participation in the study as determined by the Principal Investigator. * Inability to have baseline assessment within 60 days post-stroke diagnosis * Patient consid

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology